Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dafei Chai

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Journal of Cellular and Molecular Medicine|March 2, 2019
ISG12a and its interaction partner NR4A1 are involved in TRAIL-induced apoptosis in hepatoma cellsNianli Liu, Zhiyuan Wu, Aoxing Chen, et al.
Frontiers in Physiology|December 5, 2022
C1QBP regulates mitochondrial plasticity to impact tumor progression and antitumor immune responseQiping Wang, Dafei Chai, Navid Sobhani, et al.
Microbiologyopen|May 13, 2020
The optimization system for preparation of TG1 competent cells and electrotransformationDafei Chai, Gang Wang, Lin Fang, et al.
Frontiers in Oncology|August 18, 2023
AI-powered discovery of a novel p53-Y220C reactivatorShan Zhou, Dafei Chai, Xu Wang, et al.
Oncotarget|March 24, 2018
The development of CAR design for tumor CAR-T cell therapyDandan Xu, Guoliang Jin, Dafei Chai, et al.
Translational Oncology|December 24, 2018
Tumor-Penetrating Peptide Enhances Antitumor Effects of IL-24 Against Prostate CancerJie Yang, Hong Yin, Jie Yang, et al.
Cancers|June 24, 2022
Predictive and Prognostic Value of Non-Coding RNA in Breast CancerNavid Sobhani, Richard Chahwan, Raheleh Roudi, et al.
Journal of Immunology Research|February 10, 2018
Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell CarcinomaQing Zhang, Kang Tian, Jinjing Xu, et al.
Experimental Cell Research|July 22, 2018
AIM2 is a potential therapeutic target in human renal carcinoma and suppresses its invasion and metastasis via enhancing autophagy inductionDafei Chai, Hongjian Shan, Gang Wang, et al.
Cancer Letters|December 31, 2024
Vaccines targeting p53 mutants elicit anti-tumor immunityDafei Chai, Xu Wang, Chunmei Fan, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Journal of Cellular and Molecular Medicine|March 2, 2019
ISG12a and its interaction partner NR4A1 are involved in TRAIL-induced apoptosis in hepatoma cellsNianli Liu, Zhiyuan Wu, Aoxing Chen, et al.
Frontiers in Physiology|December 5, 2022
C1QBP regulates mitochondrial plasticity to impact tumor progression and antitumor immune responseQiping Wang, Dafei Chai, Navid Sobhani, et al.
Microbiologyopen|May 13, 2020
The optimization system for preparation of TG1 competent cells and electrotransformationDafei Chai, Gang Wang, Lin Fang, et al.
Frontiers in Oncology|August 18, 2023
AI-powered discovery of a novel p53-Y220C reactivatorShan Zhou, Dafei Chai, Xu Wang, et al.
Oncotarget|March 24, 2018
The development of CAR design for tumor CAR-T cell therapyDandan Xu, Guoliang Jin, Dafei Chai, et al.
Translational Oncology|December 24, 2018
Tumor-Penetrating Peptide Enhances Antitumor Effects of IL-24 Against Prostate CancerJie Yang, Hong Yin, Jie Yang, et al.
Cancers|June 24, 2022
Predictive and Prognostic Value of Non-Coding RNA in Breast CancerNavid Sobhani, Richard Chahwan, Raheleh Roudi, et al.
Journal of Immunology Research|February 10, 2018
Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell CarcinomaQing Zhang, Kang Tian, Jinjing Xu, et al.
Experimental Cell Research|July 22, 2018
AIM2 is a potential therapeutic target in human renal carcinoma and suppresses its invasion and metastasis via enhancing autophagy inductionDafei Chai, Hongjian Shan, Gang Wang, et al.
Cancer Letters|December 31, 2024
Vaccines targeting p53 mutants elicit anti-tumor immunityDafei Chai, Xu Wang, Chunmei Fan, et al.
Pageof 6